Gallagher Dympna, Heshka Stanley, Kelley David E, Thornton John, Boxt Lawrence, Pi-Sunyer F Xavier, Patricio Jennifer, Mancino Juliet, Clark Jeanne M
New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital, New York, NY Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY
New York Obesity Nutrition Research Center, St. Luke's-Roosevelt Hospital, New York, NY Institute of Human Nutrition and Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, NY.
Diabetes Care. 2014 Dec;37(12):3325-32. doi: 10.2337/dc14-1585. Epub 2014 Oct 21.
We aim to characterize the effects on total body fat and distribution of a 1-year intensive lifestyle intervention (ILI) for weight loss in overweight and obese adults with type 2 diabetes and to examine whether changes in adipose tissue (AT) depots were associated with changes in metabolic biomarkers.
Participants were 54 females and 38 males (age 57.8 ± 6.7 years [mean ± SD]; BMI 31.7 ± 3.5 kg/m(2)) enrolled in the Look AHEAD (Action for Health in Diabetes) trial randomized to ILI or diabetes support and education (DSE) from whom baseline and 1-year MRI measures of total AT (TAT) and regional (arm, trunk, leg) AT, including subcutaneous AT (SAT), visceral AT (VAT), and intermuscular AT (IMAT), were acquired. We tested whether mean changes in ILI and DSE were equal and, within groups, whether changes were different from zero. Regression models tested whether changes in AT compartments were associated with metabolic variable changes.
Body weight changed -0.52 ± 3.62 kg (P = 0.31) in DSE and -7.24 ± 5.40 kg (P < 0.0001) in ILI. Mean ILI changes were different from DSE (P < 0.001 for TAT, SAT, and IMAT and P < 0.01 for VAT in females). Within ILI, SAT and VAT decreased in males and females (P < 0.0001), but IMAT was unchanged (0.00 ± 0.54 kg; P = 0.99). In DSE, SAT and VAT did not change, but IMAT increased by 0.46 ± 0.55 kg (P < 0.001). Controlling for weight loss, reduction of specific AT depots was associated with improvement in metabolic biomarkers.
Weight loss of 7-10% from an ILI over 1 year reduced SAT and VAT and prevented an increase in IMAT. Reductions in AT depots were associated with improvements in biomarkers.
我们旨在描述一项为期1年的强化生活方式干预(ILI)对2型糖尿病超重和肥胖成年人总体脂肪及分布的影响,并研究脂肪组织(AT)储存的变化是否与代谢生物标志物的变化相关。
参与者为54名女性和38名男性(年龄57.8±6.7岁[均值±标准差];体重指数31.7±3.5kg/m²),他们参与了糖尿病健康行动(Look AHEAD)试验,被随机分为ILI组或糖尿病支持与教育(DSE)组,获取了他们基线及1年时的总AT(TAT)和区域(手臂、躯干、腿部)AT的MRI测量值,包括皮下AT(SAT)、内脏AT(VAT)和肌间AT(IMAT)。我们测试了ILI组和DSE组的平均变化是否相等,以及在组内变化是否不同于零。回归模型测试了AT各部分的变化是否与代谢变量变化相关。
DSE组体重变化为-0.52±3.62kg(P=0.31),ILI组为-7.24±5.40kg(P<0.0001)。ILI组的平均变化与DSE组不同(女性中TAT、SAT和IMAT的P<0.001,VAT的P<0.01)。在ILI组内,男性和女性的SAT和VAT均下降(P<0.0001),但IMAT无变化(0.00±0.54kg;P=0.99)。在DSE组,SAT和VAT未变化,但IMAT增加了0.46±0.55kg(P<0.001)。在控制体重减轻的情况下,特定AT储存的减少与代谢生物标志物的改善相关。
1年内通过ILI减重7%-10%可减少SAT和VAT,并防止IMAT增加。AT储存的减少与生物标志物的改善相关。